OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
C. Kevin, Diya Surie, Adam S. Lauring, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 9
C. Kevin, Diya Surie, Adam S. Lauring, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 9
Showing 9 citing articles:
Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination
Christine Happle, Markus Hoffmann, Amy Kempf, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 7
Christine Happle, Markus Hoffmann, Amy Kempf, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 7
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024
C. Kevin, Juan E. De Castro, Anastasia S. Lambrou, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 42, pp. 938-945
Open Access | Times Cited: 5
C. Kevin, Juan E. De Castro, Anastasia S. Lambrou, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 42, pp. 938-945
Open Access | Times Cited: 5
Understanding the Effectiveness of the Comirnaty Monovalent and Bivalent Vaccines During the Winter Coronavirus (COVID-19) Infection Survey
Thomas Ward, Robert S. Paton, Christopher E. Overton, et al.
Journal of Infection (2025), pp. 106461-106461
Open Access
Thomas Ward, Robert S. Paton, Christopher E. Overton, et al.
Journal of Infection (2025), pp. 106461-106461
Open Access
Clinical Manifestations of SARS-CoV-2 Infection in Immunocompetent Adults in the Era of Widespread Population Immunity and Omicron Sublineage Viruses
Alexander Shaffer, Eric A. Meyerowitz
Infectious Disease Clinics of North America (2025)
Closed Access
Alexander Shaffer, Eric A. Meyerowitz
Infectious Disease Clinics of North America (2025)
Closed Access
COVID-19 Surge During Summer 2024: The Phantom Menace?
Benjamin Davido, Bruno Mégarbane, Paul Loubet
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1492-1493
Closed Access
Benjamin Davido, Bruno Mégarbane, Paul Loubet
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1492-1493
Closed Access
Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines
Wei J. Chen, Kristin Tompkins, I. Windsor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Wei J. Chen, Kristin Tompkins, I. Windsor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data
Miao Miao, Yonghong Ma, Jiao Tan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Miao Miao, Yonghong Ma, Jiao Tan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes, et al.
IJID Regions (2024) Vol. 14, pp. 100503-100503
Open Access
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes, et al.
IJID Regions (2024) Vol. 14, pp. 100503-100503
Open Access
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102995-102995
Open Access
Jennifer L. Nguyen, Marianna Mitratza, Hannah R. Volkman, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102995-102995
Open Access
Limited durability of protection conferred by XBB.1.5 vaccines against Omicron-associated severe outcomes among community-dwelling adults aged ≥50 years, Ontario, Canada, September 2023 to June 2024
Nelson Lee, Lena Nguyen, Sharifa Nasreen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nelson Lee, Lena Nguyen, Sharifa Nasreen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
